Pfizer and BioNTech Provide Update on COVID-19 Vaccine Supply Agreement with the European Commission Read more about Pfizer and BioNTech Provide Update on COVID-19 Vaccine Supply Agreement with the European Commission
Changes in the Supervisory Board of BioNTech SE and Voting Results from the Annual General Meeting 2023 Read more about Changes in the Supervisory Board of BioNTech SE and Voting Results from the Annual General Meeting 2023
BioNTech Announces First Quarter 2023 Financial Results and Corporate Update Read more about BioNTech Announces First Quarter 2023 Financial Results and Corporate Update
BioNTech to Report First Quarter 2023 Financial Results and Operational Update on May 8, 2023 Read more about BioNTech to Report First Quarter 2023 Financial Results and Operational Update on May 8, 2023
BioNTech and DualityBio Form Global Strategic Partnership to Accelerate Development of Differentiated Antibody-Drug Conjugate Therapeutics for Solid Tumors Read more about BioNTech and DualityBio Form Global Strategic Partnership to Accelerate Development of Differentiated Antibody-Drug Conjugate Therapeutics for Solid Tumors
BioNTech Announces New ADS Repurchase Program Read more about BioNTech Announces New ADS Repurchase Program
BioNTech Announces Fourth Quarter and Full Year 2022 Financial Results and Corporate Update Read more about BioNTech Announces Fourth Quarter and Full Year 2022 Financial Results and Corporate Update
BioNTech and OncoC4 Announce Strategic Collaboration to Co-Develop and Commercialize Novel Checkpoint Antibody in Multiple Solid Tumor Indications Read more about BioNTech and OncoC4 Announce Strategic Collaboration to Co-Develop and Commercialize Novel Checkpoint Antibody in Multiple Solid Tumor Indications
Pfizer and BioNTech Receive U.S. Emergency Use Authorization of Omicron BA.4/BA.5-Adapted Bivalent COVID-19 Booster in Children Under 5 Years Read more about Pfizer and BioNTech Receive U.S. Emergency Use Authorization of Omicron BA.4/BA.5-Adapted Bivalent COVID-19 Booster in Children Under 5 Years
Update on First BioNTainer for African-based mRNA Manufacturing Facility Read more about Update on First BioNTainer for African-based mRNA Manufacturing Facility
